Chemotherapy in advanced prostate cancer

被引:0
作者
Beedassy, A [1 ]
Cardi, G [1 ]
机构
[1] Med Coll Penn & Hahnemann Univ, Ctr Canc, Div Hematol Oncol, Philadelphia, PA 19102 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:428 / 438
页数:11
相关论文
共 52 条
[1]  
AMATO RJ, 1988, P AN M AM SOC CLIN, V7, P207
[2]   DOXORUBICIN, MITOMYCIN-C AND 5-FLUOROURACIL IN THE TREATMENT OF HORMONE-REFRACTORY ADENOCARCINOMA OF THE PROSTATE - A SOUTHWEST-ONCOLOGY-GROUP STUDY [J].
BLUMENSTEIN, B ;
CRAWFORD, ED ;
SAIERS, JH ;
STEPHENS, RL ;
RIVKIN, SE ;
COLTMAN, CA .
JOURNAL OF UROLOGY, 1993, 150 (02) :411-413
[3]   Phase II study of estramustine and vinorelbine in hormone-refractory prostate carcinoma patients [J].
Carles, J ;
Domenech, M ;
Gelabert-Mas, A ;
Nogue, M ;
Tabernero, JM ;
Arcusa, A ;
Guasch, I ;
Miguel, A ;
Ballesteros, JJ ;
Fabregat, X .
ACTA ONCOLOGICA, 1998, 37 (02) :187-191
[4]   INDEPENDENT PROGNOSTIC FACTORS IN PATIENTS WITH METASTATIC (STAGE-D2) PROSTATE-CANCER [J].
CHODAK, GW ;
VOGELZANG, NJ ;
CAPLAN, RJ ;
SOLOWAY, M ;
SMITH, JA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (05) :618-621
[5]   PHASE-I AND CLINICAL-EVALUATION OF A PHARMACOLOGICALLY GUIDED REGIMEN OF SURAMIN IN PATIENTS WITH HORMONE-REFRACTORY PROSTATE-CANCER [J].
EISENBERGER, MA ;
SINIBALDI, VJ ;
REYNO, LM ;
SRIDHARA, R ;
JODRELL, DI ;
ZUHOWSKI, EG ;
TKACZUK, KH ;
LOWITT, MH ;
HEMADY, RK ;
JACOBS, SC ;
VANECHO, D ;
EGORIN, MJ .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (09) :2174-2186
[6]   A REEVALUATION OF NONHORMONAL CYTO-TOXIC CHEMOTHERAPY IN THE TREATMENT OF PROSTATIC-CARCINOMA [J].
EISENBERGER, MA ;
SIMON, R ;
ODWYER, PJ ;
WITTES, RE ;
FRIEDMAN, MA .
JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (06) :827-841
[7]   PROSTATE-CANCER - SCREENING, DIAGNOSIS, AND MANAGEMENT [J].
GARNICK, MB .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (10) :804-818
[8]  
GARNICK MB, 1984, NEW ENGL J MED, V311, P1281
[9]  
HERMAN EH, 1983, CANCER RES, V43, P5427
[10]  
HUDES GR, 1995, SEMIN ONCOL, V22, P41